en · de · es · fr · pt
melanotan-2-notes.peptides6823.com › Guide › Melanotan Ii Background And Mechanism — Complete Guide

Melanotan Ii Background And Mechanism — Complete Guide

By Editorial Desk · published 2026-03-21 · last reviewed 2026-04-18 · Guide

melanocortin receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

This page was last updated on 2026-04-18 and is reviewed periodically as new material appears.

Melanotan II Background and Mechanism

Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.

Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.

Chemistry and Receptor Pharmacology

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Melanotan-2 at a glance

PropertyValueNotes
Chemical classSynthetic cyclic heptapeptideMelanocortin receptor agonist
Molecular formulaC50H69N15O9Neutral form, mass near 1024.2 g/mol
Primary targetsMC1R, MC3R, MC4R, MC5RBinding is non-selective across subtypes
Related compoundsAlpha-MSH, melanotan I, afamelanotideStructurally or functionally related peptides
Common abbreviationsMT-II, MT-2Naming in the literature is not uniform

Chemical Background and Receptor Activity

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.

The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.

Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.

Related pages on this site

Melanotan-2 Structure and Receptor Pharmacology

Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Supporting material

=== Deficiency === In humans methionine is an essential amino acid; cysteine is conditionally essential and may be synthesized from non-essential serine via sulfur salvaged from methionine. Sulfur deficiency is uncommon due to the ubiquity of cysteine and methionine in food. Isolated sulfite oxidase deficiency is a rare, fatal genetic disease caused by mutations to sulfite oxidase, which is needed to metabolize sulfites to sulfates.

Among unconfirmed and often contradictory news reports aired throughout the day, one of the most prevalent claimed a car bomb had been detonated at the U.S. State Department's headquarters in Washington, D.C., but the report was retracted. Another jet (Delta Air Lines Flight 1989) was suspected of having been hijacked, but the aircraft responded to controllers and landed safely in Cleveland, Ohio. Korean Air flight 085 diverted to Whitehorse, Yukon, Canada, surrounded by police snipers and Whitehorse airport and downtown evacuated after it responded to air traffic control to transmit a hijacking code but air traffic control interpreted it to mean an actual hijack and not merely a response to air traffic request. Prime Minister Jean Chretien of Canada had given the authorization to shoot down the Korean Air Boeing 747 if necessary. A single exception to the FAA's grounding order came on September 12, when a flight was authorized from Fort Lauderdale, to San Diego, and on to Miami to retrieve a rare antivenom for a professional snake handler who had been bitten by an inland taipan. In an April 2002 interview, Mohammed and bin al-Shibh, who are believed to have organized the attacks, said Flight 93's intended target was the United States Capitol, not the White House. During the planning stage of the attacks, Atta thought the White House might be too tough a target and sought an assessment from Hanjour.

In Table 5, the approximately $85 billion fine chemical market is subdivided into major applications according to their relevance: fine chemicals for pharmaceuticals, agrochemicals, and specialty chemicals outside life sciences. Furthermore, a distinction is made between captive (in-house) production and merchant market. Pharmaceutical fine chemicals (PFCs) account for two-thirds of the total. Out of the PFC value of $55 billion, about $23 billion (~40%) are traded, and $32 billion (~60%) are the production value of the pharma industry's in-house production. Within life science products, fine chemicals for agro and veterinary drugs follow in importance. The production value for fine chemicals used for specialty chemicals other than pharmaceuticals and agrochemicals is estimated at $15 billion. As the leading specialty chemical companies (Akzo Nobel, Dow, DuPont, Evonik, Chemtura and Mitsubishi) are backward-integrated, the share of in-house production is estimated at 75%, leaving a merchant market of approximately $5 billion.

Sources: en.wikipedia.org

Notes from published material

== Post-band projects == Masters continues to create music, often of an experimental nature. His first project after Pale Saints was Spoonfed Hybrid with former A.C. Temple member Chris Trout. They released their self-titled debut album in 1993 and their second album, Hibernation Shock, in 1996. In 1994, Masters, recording under the name Pail Saint, released the album Noise Bucket on Time Stereo, the label run by His Name Is Alive auteur Warren Defever. Masters and Defever then teamed up and began to release music as ESP Summer. In autumn 1998, Masters released a 7-inch EP under the name Friendly Science Orchestra entitled Miniature Album, which became an NME 'Single of the Week'. As of 2005, Masters lived in Japan. His projects, including Wingdisk with Mark Tranmer of Gnac and the Montgolfier Brothers, can be viewed on his website, The Institute of Spoons. Naysmith and Cooper formed Lorimer, and later continued working together in the Leeds band the Terminals. The band released a single in December 2006, entitled "Dictator", on Double Dragon Records. The band changed their name again to Cyanide Pills and by 2011 had released five singles and one album on Damaged Goods Records. Naysmith and Cooper worked on a new project of atmospheric instrumental music under the name The Program. Naysmith soon formed the X-Rays Eyes alongside Cooper's bandmate Sy Shields. Naysmith died on 4 April 2024. Barham has gone on to record melodic electronica under the name Kuchen.

It is a once-weekly, two-dose antibiotic, the rights to which Actavis acquired when it bought Durata Therapeutics in 2014. The U.S. Food and Drug Administration (FDA) approved dalbavancin in May 2014, for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by certain susceptible bacteria such as Staphylococcus aureus including methicillin-susceptible and methicillin-resistant strains of Streptococcus pyogenes, in intravenous dosage form.

=== Religious beliefs === Liu was a devout Buddhist, which Lawson believe may have influenced his religious policies of tolerance and patronization toward Tibetan Buddhists. In the 1920s, when he was stationed in Luzhou, Liu, like his nephew, came under the influence of the syncretic Taoist master Liu Congyun, becoming his disciple and taking on the Dharma name of Yuyou (玉猷). Peter Gouillart, a traveller in Xikang under the employ of the Nationalists, said that Liu was "superstitious and backward" and had fallen under the control of a certain "Soong Lama". Liu also participated in fortune-telling and face reading.

Sources: en.wikipedia.org

Frequently asked questions

What class of compound is melanotan II?

It is a synthetic cyclic heptapeptide and a non-selective melanocortin receptor agonist. Structurally it is modelled on alpha-melanocyte-stimulating hormone, a peptide that occurs naturally in the body.

Does it require ultraviolet light to work?

Activation of MC1R increases pigment synthesis independently of ultraviolet exposure, which is the mechanism usually cited for darkening without sun exposure. Ultraviolet light still influences skin response through separate biological pathways.

Why is receptor selectivity discussed so often?

Because the peptide binds several melanocortin receptor subtypes, its effects are not confined to pigmentation. This complicates interpretation of both intended and unintended outcomes reported in studies.

Is melanotan II identical to alpha-melanocyte-stimulating hormone?

No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.

Network